Wearable posture device added to exercise for axial spondyloarthritis
Tests a wearable posture device added to exercise in adults with axial spondyloarthritis.
Plain-language title generated from the registry record
Registry title: Postural Biofeedback and Exercise in Axial Spondyloarthritis
Key facts
- Where
- Istanbul, TürkiyeSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with axial spondyloarthritis or ankylosing spondylitis who have back pain. It tests a wearable posture feedback device added to an exercise program.
- Age
- 18 to 65 years
- Sex
- All sexes can join.
- Disease stage
- Diagnosis of ankylosing spondylitis or axial spondyloarthritis by the modified New York or ASAS criteria, with spinal pain of at least 4 out of 10 in the past week.
- Earlier treatment
- Medical treatment must be stable, with no medication change in the previous 3 months. No regular physiotherapist-supervised exercise or rehabilitation program for axial spondyloarthritis in the previous 3 months.
Main reasons for not taking part
- Spinal surgery in the previous 6 months
- Fibromyalgia or another chronic pain syndrome that may affect pain perception
- Serious heart, lung, nerve or bone and joint conditions that prevent exercise
- Pregnancy
- Skin conditions that prevent use of the wearable device
Read by machine on 13 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07776652, who can take part
Where in Türkiye
- Istanbul University-Cerrahpasa, Faculty of Health SciencesIstanbul, TürkiyeContact: Melike N Can, PTNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Istanbul University - Cerrahpasa
- Trial code
- NCT07776652
- Record updated
- 21 August 2026
- Original description
The goal of this clinical trial is to learn whether adding a wearable postural biofeedback device to a standard exercise program affects disease activity, pain, and functional parameters in individuals with axial spondyloarthritis. The main questions it aims to answer are:Read full original descriptionShow less
The Effect of Postural Biofeedback on Disease Activity and Pain in Individuals With Axial Spondyloarthritis
The goal of this clinical trial is to learn whether adding a wearable postural biofeedback device to a standard exercise program affects disease activity, pain, and functional parameters in individuals with axial spondyloarthritis. The main questions it aims to answer are:
Does adding postural biofeedback to a standard exercise program improve disease activity? Does adding postural biofeedback to a standard exercise program reduce pain? Does adding postural biofeedback improve functional parameters, including spinal mobility, quality of life, posture, and functional exercise capacity?
Researchers will compare a standard exercise program with the same exercise program combined with a wearable postural biofeedback device to determine whether the addition of postural biofeedback provides greater benefits.
Participants will:
Participate in a physiotherapist-supervised standard exercise program twice a week for 8 weeks Use the wearable postural biofeedback device three days per week for at least 3 hours per day during prolonged static posture activities if assigned to the intervention group Complete assessments before and after the 8-week intervention, including measures of disease activity, pain, physical function, spinal mobility, quality of life, posture, and functional exercise capacity
Inclusion: Be between 18 and 65 years of age; Have a diagnosis of ankylosing spondylitis or axial spondyloarthritis according to the modified New York or ASAS classification criteria; Have had stable medical treatment with no changes in medication during the previous 3 months; Have axial/spinal pain intensity of at least 4 out of 10 on the Numeric Pain Rating Scale during the previous week; Be able to walk independently; Voluntarily agree to participate in the study and provide written informed consent.
Exclusion: History of spinal surgery within the previous 6 months; Any change in medical treatment, including biological agents or analgesic treatment, within the previous 3 months; Regular participation in a structured exercise or rehabilitation program supervised by a physiotherapist for axial spondyloarthritis within the previous 3 months; Presence of fibromyalgia or another secondary chronic pain syndrome that may substantially affect pain perception; Serious cardiopulmonary, neurological, or orthopedic conditions that prevent participation in exercise; Dermatological or allergic skin reactions or other skin conditions that prevent the use of the wearable device; Pregnancy.